Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles

PLoS Neglected Tropical Diseases

Volumn 9, Issue 12, 2015, Pages

  Zivcec, Marko ^a   Metcalfe, Maureen G ^a   Albariño, César G ^a   Guerrero, Lisa W ^a   Pegan, Scott D ^b   Spiropoulou, Christina F ^a   Bergeron, Éric ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ARTICLE; BIOSAFETY; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS ENTRY; VIRUS INHIBITION; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WESTERN BLOTTING; DNA SEQUENCE; DRUG EFFECTS; GENETIC TRANSCRIPTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NAIROVIRUS; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES; REPORTER GENE; ULTRASTRUCTURE; VIRION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84953277390     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004259     Document Type: Article

References (37)

1. Ergönül Ö, Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6: 203–214. 16554245
2. Ergönül Ö, Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol. 2012;2: 215–20. doi: 10.1016/j.coviro.2012.03.001 22482717
3. Vorou R, Pierroutsakos IN, Maltezou HC, Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis. 2007;20: 495–500. 17762783
4. Whitehouse CA, Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64: 145–60. 15550268
5. Bente DA, Forrester NL, Watts DM, McAuley AJ, Whitehouse CA, Bray M, Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antiviral Res. 2013;100: 159–89. doi: 10.1016/j.antiviral.2013.07.006 23906741
6. Sargianou M, Papa A, Epidemiological and behavioral factors associated with Crimean-Congo hemorrhagic fever virus infections in humans. Expert Rev Anti Infect Ther. 2013;11: 897–908. doi: 10.1586/14787210.2013.827890 24053271
7. Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z, A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012; 105–110. 22898483
8. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F, The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol. 2010;47: 361–5. doi: 10.1016/j.jcv.2010.01.010 20149724
9. WHOCrimean-Congo haemorrhagic fever. World Health Organization; [Internet]. [cited 18 Dec 2014]. http://www.who.int/mediacentre/factsheets/fs208/en/
10. Signs and Symptoms | Crimean-Congo Hemorrhagic Fever (CCHF) | CDC [Internet]. [cited 18 Dec 2014]. http://www.cdc.gov/vhf/crimean-congo/symptoms/index.html
11. Bergeron É, Zivcec M, Chakrabarti AK, Nichol ST, Albariño CG, Spiropoulou CF, Recovery of Recombinant Crimean Congo Hemorrhagic Fever Virus Reveals a Function for Non-structural Glycoproteins Cleavage by Furin. PLOS Pathog. 2015;11: e1004879. doi: 10.1371/journal.ppat.1004879 25933376
12. Bergeron É, Albariño CG, Khristova ML, Nichol ST, Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J Virol. 2010;84: 216–26. doi: 10.1128/JVI.01859-09 19864393
13. Devignot S, Bergeron É, Nichol S, Mirazimi A, Weber F, A Virus-Like Particle System Identifies the Endonuclease Domain of Crimean-Congo Hemorrhagic Fever Virus. J Virol. 2015;89: 5957–5967. doi: 10.1128/JVI.03691-14 25810550
14. Shtanko O, Nikitina RA, Altuntas CZ, Chepurnov AA, Davey RA, Crimean-Congo Hemorrhagic Fever Virus Entry into Host Cells Occurs through the Multivesicular Body and Requires ESCRT Regulators. PLoS Pathog. 2014;10: e1004390. doi: 10.1371/journal.ppat.1004390 25233119
15. Flick R, Flick K, Feldmann H, Elgh F, Reverse Genetics for Crimean-Congo Hemorrhagic Fever Virus. J Virol. 2003;77: 5997–6006. 12719591
16. Hepojoki J, Strandin T, Wang H, Vapalahti O, Vaheri A, Lankinen H, Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. J Gen Virol. 2010;91: 2341–2350. doi: 10.1099/vir.0.021006-0 20444994
17. Estrada DF, De Guzman RN, Structural characterization of the Crimean-Congo hemorrhagic fever virus Gn tail provides insight into virus assembly. J Biol Chem. 2011;286: 21678–21686. doi: 10.1074/jbc.M110.216515 21507948
18. Strandin T, Hepojoki J, Wang H, Vaheri A, Lankinen H, The cytoplasmic tail of hantavirus Gn glycoprotein interacts with RNA. Virology. 2011;418: 12–20. doi: 10.1016/j.virol.2011.06.030 21807393
19. Overby AK, Pettersson RF, Neve EPA, The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging. J Virol. 2007;81: 3198–3205. 17229712
20. Goedhals D, Bester PA, Paweska JT, Swanepoel R, Burt FJ, Next-generation sequencing of southern African Crimean-Congo haemorrhagic fever virus isolates reveals a high frequency of M segment reassortment. Epidemiol Infect. 2014;142: 1952–62. doi: 10.1017/S0950268814000818 24786748
21. Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST, Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol. 2006;80: 8834–42. 16912331
22. Reed LJ, Muench H, A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27: 493–497.
23. Gregory D, Pirie B, Wetting agents for biological electron microscopy. I. General considerations and negative staining. J Microsc. 1973;99: 251–255. 4131339
24. Harris JR, Bhella D, Adrian M, Recent Developments in Negative Staining for Transmission Electron Microscopy. Microsc Anal. 2006;44: 17–21.
25. Simon M, Falk KI, Lundkvist A, Mirazimi A, Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus. Virus Res. 2006;120: 184–90. 16632039
26. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S, MEGA6: Molecular evolutionary genetics analysis version 6.0. Mol Biol Evol. 2013;30: 2725–2729. doi: 10.1093/molbev/mst197 24132122
27. Bertolotti-ciarlet A, Smith J, Strecker K, Paragas J, Altamura LA, Mcfalls JM, et al. Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins. J Virol. 2005;79: 6152–6161. 15858000
28. Goedhals D, Bester PA, Paweska JT, Swanepoel R, Burt FJ, Comparative Analysis of the L, M, and S RNA Segments of Crimean–Congo Haemorrhagic Fever Virus Isolates From Southern Africa. J Med Virol. 2015; 1–8.
29. Anagnostou V, Papa A, Evolution of Crimean-Congo Hemorrhagic Fever virus. Infect Genet Evol. 2009;9: 948–54. doi: 10.1016/j.meegid.2009.06.018 19560561
30. Chen S, Molecular evolution of Crimean-Congo hemorrhagic fever virus based on complete genomes. J Gen Virol. 2013;94: 843–50. doi: 10.1099/vir.0.049379-0 23255625
31. Ferraris O, Moroso M, Pernet O, Emonet S, Ferrier Rembert A, Paranhos-Baccalà G, et al. Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules. Antiviral Res. 2015;118: 75–81. doi: 10.1016/j.antiviral.2015.03.005 25796972
32. Paragas J, Whitehouse CA, Endy TP, Bray M, A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2004;62: 21–5. 15026198
33. Watts DM, Ussery MA, Nash D, Peters CJ, Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am J Trop Med Hygene. 1989;41: 581–585.
34. Yadav PD, Cherian SS, Zawar D, Kokate P, Gunjikar R, Jadhav S, et al. Genetic characterization and molecular clock analyses of the Crimean-Congo hemorrhagic fever virus from human and ticks in India, 2010–2011. Infect Genet Evol. 2013;14: 223–31. doi: 10.1016/j.meegid.2012.10.005 23195573
35. Handke W, Oelschlegel R, Franke R, Wiedemann L, Krüger DH, Rang A, Generation and characterization of genetic reassortants between Puumala and Prospect Hill hantavirus in vitro. J Gen Virol. 2010;91: 2351–2359. doi: 10.1099/vir.0.021139-0 20505009
36. Turell MJ, Saluzzo JF, Tammariello RF, Smith JF, Generation and transmission of Rift Valley fever viral reassortants by the mosquito Culex pipiens. J Gen Virol. 1990;71(Pt 10): 2307–2312. 2230736
37. Kirsanovs S, Klempa B, Franke R, Lee MH, Schönrich G, Rang A, et al. Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains. Virus Genes. 2010;41: 319–328. doi: 10.1007/s11262-010-0523-2 20734125